http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
- 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
- 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
RISS 인기검색어
- 검색키워드
- 저자 : Kawai Tohru (검색결과 5 건)
- 무료
- 기관 내 무료
- 유료
-
비대칭 다공성 폴리(카르보벤족시-L-리신)막의 제조, 평가 및 기체투과
Kawai Tohru,Lee Young Moo,Fujita Hiroshi 한국막학회 1996 멤브레인 Vol.6 No.2
질소가스에 대한 헬륨가스의 선택도가 매우 높은 poly(carbobenzoxy-L-lysin)(PCLL)로 제조된 균일막의 투과도를 증가시키기 위해서 디옥산과 DMF의 20% 용액을 이용하여 캐스팅법으로 비대칭 다공성막을 제조하였다. 이 막에 대해서 표면에서의 공극의 수와 공극크기의 분포를 측정하였으며, 표면층의 두께는 주사전자현미경과 투과전자현미경을 이용하여 측정하였다. 평균공극크기와 평균공극밀도는 DMF용액보다 디옥산용액으로 제조한 경우 더 낮은 값을 나타내었으며, 어느 비대칭 다공성막에 있어서 공극의 형성메카니즘으로 설명할 수 있다. 투과계수는 표면층을 통한 점성흐름으로 어느 정도 설명될 수 있으나, 선택도는 점성흐름의 이론과 대치되었다. In order to improve the permeability of the homogenous membrane of poly(carbobenzoxy-L-lysin)(PCLL), which has very high selectivity of helium gas to nitrogen gas, asymmetric porous membranes of PCLL were prepared by casting from 20% solutions in dioxane and dimethylformamide(DMF), respectively. The membranes were characterized by measuring the number of the pores, the pore size distribution of the surface(the skin layer) and the thickness of the skin layer by scanning electron microscope and transmission electron microscope. The mean pore size and the pore density were lower for the membrane cast from dioxane than that from DMF, which was explained by the mechanism of the formation of the pores in the asymmetric porous membrane. The permeability coefficient observed could be roughly explained by the viscous flow through the skin layer. However, the selectivity observed was against the theory of the viscous flow.
-
Abe, Hajime,Kawai, Yuki,Mori, Tsuyoshi,Tomida, Kaori,Kubota, Yoshihiro,Umeda, Tomoko,Tani, Tohru Asian Pacific Journal of Cancer Prevention 2013 Asian Pacific journal of cancer prevention Vol.14 No.11
Background: Goshajinkigan (GJG) is used for the treatment of several neurological symptoms. We investigated the efficacy of GJG and mecobalamin (B12) against neurotoxicity associated with docetaxel (DOC) in breast cancer patients. Materials and Methods: Sixty breast cancer patients were treated with DOC. Thirty-three patients (GJG group) received oral administration of 7.5 g/day GJG and 27 patients (B12 group) received oral administration of 1500 ${\mu}g/day$ B12. Neuropathy was evaluated according to DEB-NTC (Neurotoxicity Criteria of Debiopharm), Common Terminology Criteria for Adverse Events (NCI-CTC) ver. 3.0, and a visual analogue scale (VAS). This study employed a randomized open design. Results: The incidence of neuropathy was 39.3% in the GJG group, and 88.9% in the B12 group (p<0.01). In the GJG group, grade 1 DEB-NTC was observed in 2 cases, grade 2 in 5 cases and grade 3 in 5 cases. Grade 1 NCI-CTC was observed in 7 cases, grade 2 in 6 cases, and VAS was $2.7{\pm}2.2$. In the B12 group, grades 1, 2 and 3 DEB-NTC were observed in one case, 12 cases and 12 cases, respectively; and grades 1, 2 and 3 NCI-CTC were observed in 11 cases, 12 cases and one case, and VAS was $4.9{\pm}2.4$. Conclusions: Concomitant administration of GJG is useful in preventing neuropathy in breast cancer patients treated with a DOC regimen.
-
Abe, Hajime,Mori, Tsuyoshi,Kawai, Yuki,Tomida, Kaori,Yamazaki, Keiichi,Kubota, Yoshihiro,Umeda, Tomoko,Tani, Tohru Asian Pacific Journal of Cancer Prevention 2013 Asian Pacific journal of cancer prevention Vol.14 No.8
Background: The infusion rate is considered to affect incidence and severity of infusion reactions (IRs) caused by protein formulations. Trastuzumab (TRS) is approved for 90-minute infusion as the initial dose followed by 30-minute infusion with 250 ml saline. In the study, we evaluated the safety of TRS intravenously administered over 30 minutes with 100 ml saline to reduce burden of patients, safety of infusion with 250 ml saline already being established. Materials and Methods: Women with HER2 positive breast cancer, ${\geq}18$ years and ${\geq}55%$ left ventricular ejection fraction (LVEF), were registered in the study. Patients received 8mg/kg of TRS 250 ml over 90 minutes followed by 6mg/kg of TRS 100ml over 30 minutes in a three-week cycle. Results: A total of 31 patients were recruited, 24 for adjuvant therapy and seven with metastases. The median age was 59 years (range 39 to 82). The total number of TRS doses ranged from 5 to 17 with the median of 15. Mild IR occurred in two patients at the first dose. However, no IR was observed after reducing to 100 ml saline. No decrease of LVEF, increase of serum brain natriuretic peptide or any other adverse events were reported. Conclusions: Intravenous infusion of TRS with 100 ml saline over 30 minutes in breast cancer patients can be considered safe based on results from the study. It can be given on an outpatient basis as with the currently recommended dilution in 250 ml saline.
-
Abe, Hajime,Mori, Tsuyoshi,Kawai, Yuki,Tomida, Kaori,Kubota, Yoshihiro,Umeda, Tomoko,Tani, Tohru Asian Pacific Journal of Cancer Prevention 2013 Asian Pacific journal of cancer prevention Vol.14 No.8
Background: We compared treatment completion rates and safety of docetaxel and cyclophosphamide sixcycle therapy (TC6) with docetaxel followed by 5FU, epirubicin and cyclophosphamide (T-FEC) therapy in Japanese patients with human epidermal growth factor receptor 2 (HER2)-negative breast cancer. Materials and Methods: We administered TC6 q3w or T-FEC q3w to HER2-negative breast cancer patients. The primary endpoint of this trial was toxicity. As second endpoints, the treatment completion rate and relative dose intensity were evaluated. Results: The TC6 and T-FEC group consisted of 22 and 21 patients, respectively. Concerning hematological toxicity, grade 3 or higher adverse reactions included neutropenia and febrile neutropenia. As non-hematological adverse events, exanthema and peripheral neuropathy were frequently reported in the TC6 group, whereas more patients of the T-FEC group reported nausea and vomiting. In TC6, the treatment completion rate was 86.4% and the relative dose intensity of docetaxel was 93.2%. In T-FEC, the values were 95.2% and 98.9%, respectively. Conclusions: These results suggest that TC6 is tolerable in Japanese, and that this regimen can also be performed in outpatient clinics. However, with the TC6 regimen, the compliance was slightly lower than with the T-FEC regimen, and supportive therapy needs to be managed appropriately.
-
The Production of Xylitol by Enzymatic Hydrolysis of Agricultural Wastes
Kazuhiro Takamizawa,Lien Ha Tran,Masanori Yogo,Hiroshi Ojima,Keiichi Kawai,Tohru Suzuki,Osamu Idota 한국생물공학회 2004 Biotechnology and Bioprocess Engineering Vol.9 No.3
Agricultural waste products, beech wood and walnut shells, were hydrolyzed at 40oC using mixed crude enzymes produced by Penicillium sp. AHT-1 and Rhizomucor pusillus HHT-1. D-xylose, 4.1 g and 15.1 g was produced from the hydrolysis of 100 g of beech wood and walnut shells, respectively. For xylitol production, Candida tropicalis IFO0618 and the waste product hydrolyzed solutions were used. The effects on xylitol production, of adding glucose as a NADPH source, D-xylose and yeast extract, were examined. Finally, a 50% yield of xylitol was obtained by using the beech wood hydrolyzed solution with the addition of 1% yeast extract and 1% glucose at an initial concentration.
연관 검색어 추천
이 검색어로 많이 본 자료
활용도 높은 자료
